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This study examines the communication and screening practices of healthcare 
professionals in regards to perinatal mood disorders (PMDs). Specifically, this study sought to 
understand the frequency of PMD screenings, which providers complete screenings, provider 
communication about PMDs, and women’s knowledge of PMD symptoms. Participants were 
155 mothers who completed a 16-item online questionnaire. Descriptive and inferential statistical 
analysis found PMD screening is low. Participants who were screened for PMDs were most 
often screened by prescribing providers. Results also indicate that while there is little 
communication about PMDs, oral communication is more common than written communication.  
Participants were also largely unable to identify symptoms of a common PMD; yet, knowledge 
of symptoms was not associated with age or education level. A discussion of these findings is 
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The birth of a child is usually thought of as a special time for families. Unfortunately, 
women may experience negative alterations in mood that can affect many aspects of their lives 
while adjusting to new motherhood. Throughout the years, women have been plagued by 
perinatal mood disorders (PMDs) and have been apprehensive to discuss symptoms for fear of 
being judged by their female peers and society, having their infants taken from them, and for 
various other reasons associated with fear and stigma. As a result, many women suffer in silence 
and are ashamed to admit they do not meet the societal expectations of new mothers. If PMDs 
are left untreated, conditions worsen and can lead to a host of problems, including child 
behavioral issues, poor relations between mother and child, and even mothers taking their own 
lives, or the lives of their infants (known and matricide and infanticide, respectively). PMDs do 
not exclusively affect mothers, but can also affect their spouses, growing infants, other family 
members, and friends.  
 This thesis works to supplement existing research with the intention of creating more 












 Perinatal mood disorders (PMDs) can lead to severe problems for new mothers, and their 
newborns (NIMH, n.d.). Chemical alterations in the brain, as well as consistent insomnia, 
feelings of isolation, and lack of support can all lead to development of PMDs, such as 
postpartum depression (PPD), perinatal anxiety, postpartum obsessive-compulsive disorder 
(POCD) and postpartum psychosis (PPP) (NIMH, n.d.). This literature review will explore these 
conditions as well as screening and treatment options, societal stigmas affecting new motherhood 
and PMDs.  
Explaining Perinatal Mood Disorders 
Good Housekeeping magazine showcased the term postpartum depression in the year 
1960. There was not, however, a definitive distinction between PPD and the baby blues, a 
common short-lived response to new motherhood resulting from hormonal fluctuations (Held & 
Rutherford, 2012). In fact, PPD was not recognized as a mood disorder separate of major 
depressive disorder (MDD) until the release of the DSM-V in May of 2013 (Segre & Davis, 
2013). Today, 10-20% of new mothers suffer from perinatal anxiety or depression, two common 
PMDs. This is a conservative figure as many women do not report their symptoms and are not 
screened or diagnosed for PMDs.  
 New mothers should seek immediate care if experiencing symptoms of a PMD (APA, 
2014). Yet, that is often difficult as many women are not screened for PMDs, and others with 
symptoms may suffer in silence due to fears associated with perceptions of her ability as a 
mother (Howorth, 2017). Left untreated, mothers suffering with PMDs may have trouble 
connecting with their children, which can negatively impact their children’s overall development 
and health (AWHONN, 2015). Additionally, it is also important to identify the potential 
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consequences during the prenatal period. While a woman is pregnant and is experiencing 
negative alterations in mood, she may not adhere to proposed medical care and may be more apt 
to consume less nutritious foods (Kendig et al., 2017). Additionally, she may undergo weight 
changes, begin to smoke, or partake in substance abuse if she is struggling with symptoms of 
PMDs during her pregnancy (Kendig et al., 2017). If a mother with PMDs is not properly 
diagnosed, does not report symptoms, or is resistant to appropriate treatment protocols, it may 
result in inhibited interactions between the mother and her infant (Yawn, Kurland, & Bertram, 
2013). Subsequently, the child may have trouble interacting with and amongst peers, experience 
behavioral issues, and suffer with cognitive abilities (Yawn et al., 2013). 
 Another significant consequence of PMDs in the United States is suicide, which 
“accounts for about 20 percent of postpartum deaths and is the second most common cause of 
mortality in postpartum women” (Bamforth, 2016, para. 6). In the UK, suicide is among the 
leading causes of death in new mothers (Oates, 2003). Suicides among mothers (matricide) 
during the first twelve months are not recognized as “pregnancy-related deaths” (Stone, n.d.). 
Rather, these matricides are viewed as “pregnancy-associated deaths,” which are not necessarily 
deemed as biological in nature (Stone, n.d.). The definition of “pregnancy-related death,” is the 
death of a women during pregnancy, or within one year of the end of pregnancy, due to a 
pregnancy complication, a chain of events caused by pregnancy or birth, or the worsening of an 
unrelated condition in the mother, due to pregnancy or birth (Stone, n.d.).  
Unfortunately, matricide and infanticide are potential outcomes of untreated PMDs, and 
are not uncommon. Brockington (2004, p. 307) states that, “obsessions of infanticide were one of 
the first postpartum disorders to be described.” Further, it is worth noting that untreated PMDs 
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can lead to infanticide, highlighting the importance of being proactive about diagnoses and 
treatments, rather than reactive about PMDs, such as postpartum depression (Anderson, 2013). 
Perinatal Mood Disorders 
 This PMD review will include an overview of postpartum depression (PPD), perinatal 
anxiety, and postpartum OCD (POCD). Even though some PMD symptoms are common across 
all three conditions, there are some symptoms that distinctly separate the conditions from one 
another. 
Postpartum Depression (PPD) 
 It is believed that as many as 1 in 7 women develop PPD, but that the condition is 
thought to be underreported, due to a number of factors, including stigma and lack of knowledge 
about the condition (Anderson, 2013). Symptoms of progressive PPD can include anxious 
tendencies, sadness, tiredness, appetite disruption, and “self-deprecatory thoughts” (Millis & 
Kornblith, 1992, p. 193). These symptoms can intensify over time and can result in a woman 
having suicidal thoughts, or thoughts of harming her newborn baby (Millis & Kornblith, 1992). 
Despite severe risks associated with PPD, many women are reluctant to seek help or 
acknowledge the condition’s effects (Anderson, 2013). PPD is not always a short-term condition 
and can last for years without appropriate treatment. If left untreated, women are subject to many 
risks, including matricide (NIMH, 2014). PPD does not discriminate and exists across the 
socioeconomic spectrum, as well as across all age ranges and races (Camp, 2013). In addition, a 
mother’s entire family can experience repercussions from her physical and mental state if the 
mother struggles with PPD (Camp, 2013).  
 PPD often materializes as depressive symptoms that occur for more than two weeks in 
duration, immediately following childbirth (Camp, 2013). Even though PPD is different than the 
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baby blues, women may have a difficult time deciphering between the conditions, due to similar 
symptomatology. The baby blues are viewed as being very common, usually spanning the course 
of up to two weeks, and resolves as hormones return to pre-pregnancy levels. PPD, however, can 
manifest itself around one week and even one month after a woman has delivered her baby 
(NIMH, 2014). While PPD occurs in 10-20% of new mothers, 80 percent of new mothers 
experience baby blues, which makes this occurrence more common, and more expected for new 
mothers (AWHONN, 2015). PPD differs from the baby blues in parameters such as duration of 
condition, severity of symptoms, and percentage of the population (NIMH, 2014). As a more 
extreme and dangerous form of depression, PPD can also lead to PPP if left untreated (NIMH, 
2014). PPP is a much more serious condition that includes symptoms like hallucinations and 
delusions and an altered sense of reality (Edwards & Timmons, 2005). Despite the prevalence of 
PPD and its resulting symptoms, more research is needed to fully understand how this disorder 
affects mothers and their loved ones.  
Perinatal Anxiety 
 Perinatal anxiety conditions are underestimated and are likely more prevalent than even 
PPD (Brockington, 2004). The prevalence of anxiety in perinatal women is significant, with 13 
to 21% estimated to have prenatal anxiety and 11 to 17% to have postpartum anxiety (Kendig et 
al., 2017). Mothers with perinatal anxiety can experience symptoms such as excessive worry, 
difficulty being still, ruminating thoughts, and appetite disruptions (PSI, n.d.). Furthermore, 
physical symptoms may also develop, such as stomach upset, dizziness, and even hot flashes 
(PSI, n.d.).  
Based on research outlined in Brockington (2004), various fears may arise as symptoms 
of perinatal anxiety, such as the fear of losing an infant due to sudden death (Brockington, 2004). 
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Enhancing anxiety is that a mother may have difficulty sleeping, due to the heightened 
sensitivity to her infant’s breathing. Thus, mothers may find themselves sleep deprived if they 
are consistently checking in on their sleeping infants (Brockington, 2004). This combination of 
prolonged sleep deprivation and persistent anxious thoughts can eventually manifest into 
depressive symptoms (Dennis, Falah-Hassani, Brown, & Vigod, 2016). Based on the 
aforementioned information, there is a need to identify various psychological, biological, and 
psychosocial risk factors that play a role in the development of perinatal anxiety, in order to 
possibly mitigate symptoms (Dennis et al., 2016).  
Postpartum Obsessive Compulsive Disorder (OCD) 
Women experience various hormonal changes throughout the course of their pregnancies 
(Altemus, 2001; Chaudron, 2010; Stein et al., 1993). Chaudron (2010) notes that when two 
hormones, estrogen and progesterone, suddenly shift, a disruption in the transmission of 
serotonin may occur. This disruption may be a factor contributing to obsessive compulsive 
symptoms (OCS) and obsessive compulsive disorder (OCD) (Chaudron, 2010; Williams & 
Koran, 1997). This rapid change can cause postpartum OCD to present itself as soon as one week 
after a woman gives birth (Abramowitz, 2007). Some research indicates that a larger than normal 
percentage of perinatal women with previously diagnosed OCD have reported that their OCD 
worsened during their pregnancies and during the postpartum period (Abramowitz, 2007).  
Postpartum OCD can be extremely scary, with women experiencing images of their 
babies being dead and thoughts of drowning, stabbing, or dropping their babies (Abramowitz, 
2007). Other actions that are indicative of mothers with postpartum OCD include consistently 
checking on children, praying obsessively, and seeking reassurance by constant research about 
symptoms (Abramowitz, 2007). Even though Postpartum OCD consists of mothers having 
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thoughts of attacking their children, these thoughts do not typically include anger and these 
thoughts are not indicative of child abuse (Brockington, 2004). These feelings can result in 
distress, which can lead to a reduction in mother-baby interactions (Brockington, 2004). A 
mother who suffers from OCD often exhibits gentleness toward her infant, combined with 
infanticidal impulses, and has visions of her family’s shock and sadness if any harm is inflicted 
on the infant (Brockington, 2004).  
Societal Stigmas about Motherhood  
 Research shows that women may often be disinclined to discuss their symptoms with 
family, friends, or healthcare providers, in fear of having their babies taken away from them or 
being judged (Anderson, 2013). Postpartum women may experience guilt if they do not feel 
instant joy upon delivery of their newborns, due to the idea of childbirth being characterized as a 
happy time for new mothers (Anderson, 2013). Even before postpartum women give birth, there 
are a numerous pressures placed upon them to perform motherhood; these pressures can be 
overwhelming, to the detriment a woman’s health and the health of their unborn child 
(O’Connor, 2017). Depictions of new mother euphoria are widely distributed by popular media, 
which can lead to mothers feeling apprehensive about sharing thoughts of despair with others 
(Gruen, 1990). These media messages set up an ideology of the good mother and the bad mother, 
and mothers with PMDs do not fit the good mother mold (Douglas & Michaels, 2005).   
Women who experience symptoms of PMDs may think that society views them as 
mentally incompetent, so they are hesitant to let others know of their struggles (Kingston et al., 
2014). Should a new mother express feelings of distress, she may be advised by healthcare 
providers and/or family members to engage in an evening out with her spouse/significant other, 
buy something new, or try to get some exercise (Gruen, 1990); however, PMD symptoms are not 
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addressed by material objects and a night out. In addition to being plagued by thoughts of 
societal judgment, mothers may be apprehensive to disclose information because they feel their 
needs might be overlooked or misconstrued by family, friends, or healthcare professionals. 
 Mauthner (1999) studied women with PPD and found they placed a great deal of pressure 
upon themselves in their roles as mothers. The reality of actual motherhood conflicted greatly 
with these women’s initial expectations. Mauthner identified that mothers had their own ideas 
regarding what constitutes a good mother, specifically noting that some of those ideas included, 
“a natural, drug-free delivery,” the ability to breastfeed their infants, being able to stay-at-home, 
and being a super mother (i.e. the mother who does it all) (Mauthner, 1999, p.152). Kingston et 
al. (2014) explain that new mothers who interact with other mothers who seem confident about 
motherhood may feel forced to show elation and confidence, even though that is not how they 
truly feel.  
The pressure to be a good mother can also lead to mothers being fearful of discussing 
PMD symptoms, due to the possibility of individuals judging them as failures (Kingston et al., 
2014). Douglas and Michaels (2005) elaborate on the societal demands of mothers doing 
everything the correct way, enjoying every waking moment of it, and if women don’t love all 
aspects of motherhood, they are not good moms. If women don’t succeed in meeting their lofty 
self-expectations, they may feel guilty, place blame on themselves, and classify themselves as 
bad mothers (Douglas & Michaels, 2005).  Douglas and Michaels note some statistics about the 
difficulties of being a mother, where 81% of women stated in a poll that mothering is harder now 
than twenty or thirty years ago. In that same poll, the number of women who thought mothers 
aren’t doing a good enough job versus 20 to 30 years ago was 56%. These repetitive, self-
deprecatory thoughts about can multiply in intensity and eventually lead to the onset of PMDs.   
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In order to show improvements in outcomes, screening for PMDs should be combined with 
components of care, such as psychiatric referrals.  
Postpartum women are not able to appropriately express their feelings of sadness due to a 
lack of compassionate relationships and the public’s misrepresentations of PPD (Mauthner, 
1999). The general public seems to place judgment on and offer unwarranted advice to mothers 
in common places, such as grocery stores, coffee shops, and shopping malls (Howorth, 2017). 
Women are repeatedly fed information and unsolicited advice from society in general about 
pregnancy and motherhood in abundance (Douglas & Michaels, 2005). This information 
overload can cause women to question their own mothering practices, judge other women’s 
practices, and compete with other mothers (Douglas & Michaels, 2005). Postpartum women may 
doubt themselves even more when friends and family members become judgmental and are not 
supportive of expressed feelings (Mauthner, 1999). Based on the these fears of societal and 
familial judgment, new mothers may be unwilling to search for healthcare, which in turn, leaves 
them without the help they need to address their PMD symptoms.  
Research by Edwards and Timmons (2005) examined mothers’ experiences with stigma, 
as well as how they viewed themselves in their roles as mothers. The authors noted that one of 
the participants, who had been a patient in a mother-baby unit, stated that she was “really 
paranoid about what people would think,” and also said, “I didn’t want my husband to tell 
anybody where I was” (Edwards & Timmons, 2005, p. 475). The participant elaborated by 
stating, “I didn’t want people to know I had a mental illness, I would have preferred them to 





PMD Screening Tools 
 Given societal understandings of motherhood and the resulting guilt of not being a 
“good” mother, many women suffer with PMDs in silence, choosing to tell no one of their 
symptoms (Pinto-Foltz & Logsdon, 2008). Thus, it is important that screening for PMDs take 
place in order to identify new mothers who may be struggling in their new role (Tam, Newton, & 
Parry, 2002). The Association of Women’s Health, Obstetric, and Neonatal Nurses (AWHONN) 
(2015, p. 687) states that, “all pregnant and postpartum women should be screened for mood and 
anxiety disorders.” A key element for reducing mortality in postpartum women is to perform 
earlier screening (in the prenatal phase) to identify women who may be at a higher risk for 
developing mood disorders (Johns Hopkins Medicine, 2013). Despite the need for screening, and 
the existence of PMD screening tools, only 18% of physicians participate in active screening 
utilizing designated PPD screening tools (Yawn et al., 2013).  
There are a number of diagnostic screening tools available to healthcare providers. 
However, PPDs are often hard to diagnose, due in part to a historical lack of psychiatric 
diagnostic parameters. The American Psychological Association’s Diagnostic and Statistical 
Manual of Mental Health Disorders did not, until recently, include PPD as a classification apart 
from major depressive disorder. In fact, The DSM-IV, published in 1994, was the first version 
that stated depression can occur with postpartum onset (Segre & Davis, 2013). Unfortunately, 
this indicator was applicable to other disorders, such as Major Depressive Disorder, Bipolar I 
disorder, and Bipolar II disorder (Segre & Davis, 2013; APA, n.d.). The DSM-V, after being 
pressured by members of Postpartum Support International, does include more specific 
indicators of peripartum onset. While this revision is an advancement in the definition of PMDs, 
the revision did not change the time-frame for which a PMD must be diagnosed. The revision 
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still indicates that a PMD is diagnosable within four weeks postpartum, despite several studies 
that indicate conditions like PPD manifesting up to one year after childbirth (APA, n.d.). 
Despite the difficulty in diagnosing PMDs, there are several measures available for 
physicians to screen for these conditions. Beck established the Postpartum Depression Screening 
Scale (PDSS), as well as the Postpartum Depression Predictors Inventory-Revised (PDPI-R) 
scale (Beck, Records, & Rice, 2006). Both contain questions geared more specifically toward 
postpartum depression, versus general depression, as is the case with the Beck Depression 
Inventory (BDI) (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). The BDI is a screening tool 
commonly used to diagnose PPD prior to the development of PPD-specific measurements like 
the PDSS and PDPI-R. While the BDI considered factors such as insomnia and fatigue, the BDI 
was deemed as being potentially unsatisfactory for the discovery of PPD (Beck & Gable, 2000).  
The psychometric properties of the PDSS made improvements in the detection process of 
PPD (Beck & Gable, 2000) and was based on comments from female research participants in 
Beck’s PPD research study (Beck & Gable, 2000). Building upon the PDSS, the PDPI-R 
measures “13 risk factors reported to significantly related to the development of PPD” (Beck et 
al., 2006). Questions are asked by healthcare professionals in an interview format in order to 
foster a discussion about symptoms and to enable women to voice concerns about these risk 
factors (Beck et al., 2006). 
 Another tool, the Edinburgh Postnatal Depression Screening Scale (EPDS) is a screening 
tool used for measuring a broad spectrum of perinatal mood disorders (Brockington, 2004). The 
(EPDS) offers specific screening properties for PPD and can also be effective at screening for 
anxiety (Beck & Gable, 2000). Additionally, the National Institute for Health and Clinical 
Excellence (NICE, 2014) recommends the GAD-7 (Generalized Anxiety Disorder-7) for 
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perinatal anxiety screening (Ashford, Ayers, & Olander, 2017). The GAD-7 is appropriate for 
screening for generalized anxiety disorder during the antenatal and postnatal periods (Ashford et 
al., 2017).  
 There are also screening tools for OCS and OCD, including the Yale-Brown Obsessive-
Compulsive Scale (Y-BOCS), which is classified as the best instrument for the assessment of 
OCS and OCD (Chaudron & Nirodi, 2010). The severity of symptoms is measured in five 
different groups, ranging from sub-clinical to extreme, and the screening can be done over the 
phone. While the Y-BOCS has not been validated for perinatal or postpartum screening, the scale 
has been utilized in research with perinatal women (Chaudron & Nirodi, 2010).  
 The Mood Disorder Questionnaire (MDQ) is a screening tool that is not as widely used to 
screen for PMDs as some aforementioned measurements. The MDQ has been utilized for bipolar 
disorder screening (Merrill et al., 2015). The MDQ is a brief screening that is used mostly in the 
primary care sector (Hirschfeld et al., 2003). A study by Sharma and Xie (2011), however, 
indicates its usefulness for screening during the postpartum period (Merrill et al., 2015).  
 Recommendations for screening women routinely are supported by groups, such as the 
American Academy of Pediatrics (AAP) and the Australian Midwifery Association. On the 
contrary, there some organizations, such as the American College of Obstetrics and Gynecology 
(ACOG), The U. S. Agency for Healthcare Research and Quality (AHRQ), and U. S. Preventive 
Services Task Force (USPSTF) think that there is a lack of evidence to suggest universal PMD 
screening practices (Yawn, LaRusso, Bertram, & Bobo, 2015). 
PMD Treatment Options 
PMDs are generally treated based on the needs of individual patients (Gray, 2018). 
Traditional treatment options for PMDs include drug therapy, cognitive behavioral therapy 
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(CBT) with a clinical psychologist, psychotherapy, and monitored inpatient treatment at mother-
baby facilities (Brockington, 2004).  Some new mothers are apprehensive about taking oral 
medications, like antidepressants, anxiolytics, sleep-aids, and antipsychotics, if they are 
breastfeeding (Gray, 2018). Therefore, psychotherapy and CBT are both successful methods of 
treatment and have been widely reported in psychological research (Gray, 2018).  
It is important to note that what works for one mother may not work for another. Some 
mothers require one type of treatment approach, whereas another mother may require a multi-
faceted treatment plan (Brockington, 2004). In recent years, additional nonpharmacological 
therapies have been utilized for treatment of PMDs, such as Internet-based education and 
behavioral activation. Technological advances create more opportunities for mothers to receive 
care in non-traditional ways, without being forced to see healthcare providers in office settings. 
This is important because technology can provide quicker treatment options. Beck and Gable 
(2000) explained that the duration of PMDs can be prolonged if there is a delay in the 
administration of appropriate treatments.  
Self-help via Internet-based education that can be sought by the patient, or in 
combination with a healthcare provider (Ashford, 2017). These treatment methods give mothers 
the latitude to engage in treatment while still meeting the needs of their babies’ feeding and 
sleeping schedules (Ashford, 2017; McDaniel, Coyne, & Holmes, 2012). In addition, this method 
of therapy allows mothers more privacy and may reduce fears associated with social stigma and 
expectation of new mothers (Ashford, 2017; Woolhouse, Brown, Krastev, Perlen, & Gunn, 
2009). Financially, web-based therapies may cost less than visiting a provider in a one-on-one 
setting (Ashford, 2017). In a 2017 study, Ashford found women noted high interest in Internet-
based therapies.  
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Another nonmedicinal intervention explained by Dimidjian et al. (2017) is Behavioral 
Activation (BA). Dimidjian et al.’s study is the first of its kind to test BA efficacy compared to 
treatment as usual among women during pregnancy. BA emphasizes how depression relates to 
“shifts in life context and on the maladaptive links that can develop between mood and reduced 
activity, and increased withdrawal, avoidance, and routine disruption” (Dimidjian et al., 2017, p. 
27). Intervention methods help break cycles of depression by guiding individuals to increase 
their activities, to problem solve, and to surround themselves with other people or practices that 
can foster rewards (Dimidjian et al., 2017). Dimidjian et al. (2017) demonstrate that BA treated 
women experience significantly lower amounts of depressive symptoms, as well as significant 
benefits regarding anxious symptoms (p. 33).  
There are many different PMD treatment options for healthcare professionals to take into 
consideration, such as CBT, prescription medications, Internet education, and Behavioral 
Activation. Even though healthcare providers may suggest treatments they believe are best for 
their patients, women may have opposing views, especially when it comes to taking prescribed 
medications. It is important for patients and healthcare professionals to decide on the best 
therapeutic option(s) in a collaborative manner.  
Importance of this Study 
There are myriad resources available for screening for PMDs, and a number of treatment 
options available to address symptoms of various PMDs. Yet, scores of women suffer with 
PMDs silently, choosing not to disclose their symptoms for fear of being judged by peers, family 
members, or healthcare providers. Others suffer because they are not screened for PMDs by 
qualified practitioners. As such, it is important to understand the communication, both written 
and oral, that exists between women and their healthcare providers about PMD symptoms, 
15 
 
screening, and treatment options. It is also important to understand who is providing that 
communication and when that communication is taking place, as it is important to educate 
women about these potential issues prior to delivery in an effort to ensure women are aware of 
PMDs and feel confident in their ability to disclose symptoms and engage in treatment. It is 
equally important to understand whether women are being screened for PMDs as early screening 
can lead to more timely and more effective treatment. 
Research Questions and Hypotheses 
This study had a number of objectives. First, this study sought to determine whether or 
not women were being screening for PMDs and, if so, by whom. Second, this study investigated 
women’s knowledge of common PMD symptoms. Third, this study explored provider 
communication about PMDs. Lastly, this study explored the relationships between age and 
education level and knowledge of a common PMD. Given these goals, the following research 
questions are posed: 
RQ1: When do women report being screened for perinatal mood disorders? 
RQ2: Which healthcare professionals are performing screenings for perinatal mood 
disorders? 
RQ3: What is the nature of physician communication about PMDs to women? 
In addition, two hypotheses are presented. These hypotheses are posited based on an 
understanding of Tichenor, Donohue, and Olien’s (1970) Knowledge Gap Hypothesis. The 
Knowledge Gap Hypothesis suggests that information is not acquired evenly by all members of a 
society. Instead, people with a higher socioeconomic standing are better positioned to acquire 
information. One reason for this is that individuals from higher socioeconomic classes may also 
have access to better education and have higher education levels. While age is not specifically 
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addressed by Tichenor, Donohue, and Olien, it is expected that as a person will be exposed to 
more information over time thereby increasing their knowledge of a specific topic. Thus, the 
following hypotheses guiding this study are as follows: 
Hypotheses 
H1: There is a relationship between participant age and knowledge of postpartum 
depression (PPD).  
H2: There is a relationship between participant education level and knowledge of PMDs.  
Methodology 
The following section will explain this study’s research design and survey instrument, as 
well as provide information about the participants and recruitment process. 
Participants 
Participants included 175 women; however, 20 questionnaires were not analyzed due to 
partial completion. The final survey sample consisted of 155 participants. Participant ages ranged 
between 18 and 55+, with the majority of participants (43.2%) being 35-44. The sample was 
well-educated as 69% of participants reported obtaining a bachelor’s degree or higher. See Table 
1 for a breakdown of participant demographic information:  
Table 1. Participant Demographics 
Education Level n % Age n % 
Did Not Complete High School 1 0.6 18-24 2 1.3 
High School Graduate 4 2.6 25-34 57 36.8 
Some College 34 22 35-44 67 43.2 
Associate’s Degree 9 5.8 45-54 20 12.9 
Bachelor’s Degree 49 31.6 55+ 9 5.8 
Master’s Degree 47 30.3    
Doctoral Degree 9 5.8    
Professional Degree (i.e., JD, 
MD) 





Research Design and Survey Instrument 
This study employed a convenient snowball sample. Participants included women ages 
18 and older who had given birth. A 16-item online questionnaire (See Appendix B) was 
available through the Survey Gizmo (surveygizmo.com) platform for a period of one month 
during January of 2018. An online questionnaire enabled participation by women across the 
world, as an online questionnaire transcends geographic barriers imposed by face-to-face 
questioning (Wright, 2005). Furthermore, the online questionnaire provides confidentiality, 
which is more difficult to secure face-to-face. In addition to questions related to demographics, 
question included ones related to PMD screening, knowledge about PMDs, and communication 
about PMDs. 
While this was a minimal risk study, efforts were made to ensure ethical treatment of 
participants. There were no participant identifiers and the study was approved by the Johns 
Hopkins University Institutional Review Board. All participants were required to acknowledge 
receiving informed consent by dating an online informed consent page before beginning the 
questionnaire. Participants took, on average, four minutes to complete the questionnaire.  
Recruitment letters (See Appendix A) were distributed via email and social media to 
members of the principal investigator and student investigator’s personal and professional 
networks. Social media platforms included Facebook, Twitter, and LinkedIn. As this study 
employed a convenient snowball recruitment strategy, participants were asked to forward the 
questionnaire link to members of their networks who fit the inclusion criteria (females 18 or over 
who had given birth). Study participants were not responsible for any research-related costs, and 
were not offered incentives for their participation in this research. No direct identifiers were used 
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to maintain confidentiality. As this was a snowball study, there was a slight risk that participants 
may know one another and discuss survey questions in advance. 
Data was collected via the Survey Gizmo platform’s data collector. After the one-month 
data collection period, the collector was closed, which meant anyone who tried to access the 
survey was informed the study was no longer available.  
Data Analysis 
 Survey Gizmo’s data features provide descriptive statistics including measures of central 
tendency and variability. The Survey Gizmo platform provides this information in both chart and 
graph format and also allows data to be downloaded for additional statistical probing. The 
research questions were answered using the descriptive statistics provided by the platford, 
specifically the use of frequencies. To determine the existence of a relationship, data was 
downloaded to an Excel spreadsheet and analyzed using the XLSTAT program, an add-on Excel 
program that provides for more sophisticated statistical analysis. Correlation tests were 
performed to determine outcomes for each hypothesis.  
 The Pearson correlation measures the strength of the relationship between two variables. 
The correlation takes place on a range from +1 to -1. Values of zero indicate that no relationship 
exists between variables while values closer to +1 or -1 indicate the existence of either a positive 
or negative relationship between variables.  
Reliability and Validity 
Reliability and validity are difficult to ensure in a study that uses a new measurement. 
While there was no measure of reliability, due to self-administration of the questionnaire, 
reliability can be somewhat ensured through test-form consistency and a lack of alteration in 
delivery method. Without an investigator or proctor administering the questionnaire, there was 
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no opportunity for deviation in question verbalization to participants (Jones & Kottler, 2006). 
One way to improve upon reliability is with by having participants complete the questionnaire 
again at a later date. Known as test-retest reliability, this method ensures that answers remain the 
same over time. The test-retest method assumes there is no change to the construct or to the 
instrument and that retest participants also completed the first questionnaire. While test-retest is a 
feasible means of estimating reliability in studies without control groups, there is no reliability 
information until the retest is completed. A retest was not completed for this study due to time 
limitations and the fact that participants name and contact information was not collected.  
The study does employ face and content validity. Face validity is simply determining 
whether the instrument “on its face” is a good translation of the construct being measured. This 
type of validity, while perhaps weak, was demonstrated through questions that were applicable to 
the study’s research questions and hypotheses, and also applicable to the study of PMDs, based 
on previous studies (Anderson, 2011). Content validity, also called rational validity, indicates 
whether the questions asked are related to the main construct or actually measure something else. 
In this study, questions were asked that inform communication about and knowledge of PMDs. 
One way of determining content validity is to employ a panel of experts to determine how they 
rate the usefulness of questions in measuring the construct. This study relied on the expert 
knowledge and guidance of a health communication scholar; however, using an expert panel in 
advance to help determine question efficacy would allow for revisions to the instrument prior to 
making it available to participants.  
In addition to reliability and validity, Survey Gizmo provides an accessibility and fatigue 
rating for questionnaires. This study’s questionnaire had a low fatigue rate, indicating less 
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chance of participant abandonment, and high accessibility, meaning it is operable, 
understandable, and robust.   
Findings 
This section will explore the findings of this study. This section is separated by each 
research question and hypothesis.  
RQ1: When do women report being screening for perinatal mood disorders? 
The first research question asks, “When do women report being screened for perinatal 
mood disorders?” Descriptive statistics were used to determine whether or not participants were 
screened for perinatal mood disorders. If participants were screened, they identified when the 
screening took place. Most participants (n=99, 63.9%) indicated they were never screened for 
mental health conditions. Of those who were screened,  (n=51, 32.9%) reported being screened 
after delivery while 11 (7.1%) participants reported being screened during their pregnancies and 
only nine (5.8%) participants reported being screened at their first prenatal visit. The findings of 
this RQ clearly indicate that mental health screening did not occur in the majority of the sample. 
RQ2: Which healthcare professionals are performing screenings for perinatal mood 
disorders? 
The second research question asked about the healthcare professionals who are 
performing screenings for perinatal mood disorders. Participants only answered this question if 
they responded that they had been screened for PMDs, but could select as many answers as 
applied to their situation. Thus, if a woman was screened by both a physician and a nurse, she 
could choose two answers.  As found in RQ1, most participants did not report being screened for 
PMDs. However, of the 56 women who reported being screened (44.8%), were screened by 
either physicians, nurse practitioners, or physician assistants (providers licensed to prescribe 
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medications); a total of 22.4% were screened by nurses; another 12.7% were screened by doulas; 
and 9.9% were screened by other office of hospital staff. A smaller group of 4.2% answered 
“other” and were prompted to explain who performed their screenings. The one participant who 
provided an explanation as to who performed her screening, stated: I have had three children and 
was only screened after the birth of my third child - and only after extensive conversations with 
my OB about my previous experiences with PPA and PPD - I'm not sure that I would have been 
screened without those conversations. 
RQ3: What is the nature of physician communication about PMDs to women? 
The third research question asked, “What is the nature of physician communication about 
PMDs to women?” Participants were asked to indicate whether they were offered literature on 
PMDs and also whether they engaged in oral discussions about PMDs with a healthcare 
provider. If participants were offered literature, they were asked to identify the phase of 
pregnancy they received the literature.  
Most participants (n=81, 52.3%) indicated that no perinatal mental health literature was 
offered to them at any time before, during, or after pregnancy. Of those who did receive 
literature, 31.6% (n=49) said they were offered information after delivery, 27.7% (n=43) were 
offered literature during pregnancy, and 1.9% (n=3) were offered literature at their first prenatal 
visit. These findings demonstrate that most women in this study did not receive written 
information about PMDs and of those who did, most were given information only after delivery.  
Oral communication between participants and providers was slightly higher. A total of 61 
participants (39.4%), reported that PMD information was not discussed at any time by healthcare 
providers. However, 67 participants (43.2%) indicated they engaged in PMD discussions after 
delivery. Another 47 participants (30.3%) stated that healthcare providers engaged in PMD 
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discussions during pregnancy. Only four participants (2.6%) noted engaging in discussions with 
healthcare providers during their first prenatal visit. Thus, while many participants did not 
receive oral information about PMDs during any phase of pregnancy, the majority of participants 
reported engaging in discussion about PMDs at some time during pregnancy, most often after 
delivery.  
H1: There is a relationship between participant age and knowledge of postpartum 
depression (PPD). 
 The first hypothesis predicted an association between participant age and knowledge of 
symptoms of a common PMD, postpartum depression, based in part on an explication of the 
Knowledge Gap Hypothesis.  A Pearson correlation was obtained to test this association. No 
relationship was found to exist between age and knowledge of common PPD symptoms (r = 
0.015; p = .857). Thus, I fail to reject the first null hypothesis.  
H2: There is a relationship between participant education level and knowledge of PMDs. 
 The second hypothesis predicted an association between participant education level and 
knowledge of symptoms of PPD. This hypothesis was also based on an understanding of the 
Knowledge Gap Hypothesis. A Pearson correlation was obtained to test this association. No 
relationship was found to exist between education level and knowledge of common PPD 
symptoms (r = -0.089; p = .271). Additionally, there was no relationship between education level 
and familiarity of PMD symptoms prior to giving birth (r = .37; p = .648). These results indicate 
that women do not have greater knowledge of PMDs at any one specific time; thus, I fail to 






This study sought answers to three research questions that pertained to issues such as 
PMD screening practices, women’s knowledge of common PMD symptoms, and provider 
communication about PMDs. Additionally, this study predicted relationships in two hypotheses: 
participant age and knowledge of PPD and participant education level and knowledge of PMDs. 
The Knowledge Gap Hypothesis (Tichenor et al., 1970) served as the foundation for testing these 
hypotheses. The following discussion elaborates on the findings of this study, explains the 
limitations of this study, and outlines recommendations for future research. Discussion is 
provided for the research questions first, followed by the hypotheses.  
Discussion of Research Questions 
Screening for PMDs plays an integral role in the process of discovering symptoms, 
initiating a course of treatment, and ultimately providing a road to recovery for women who have 
these conditions. In this study, it was found that over half of participants (63.9%) indicated they 
were never screened for mental health conditions and 32.9% of participants were screened after 
delivery. Previous research suggests that screening should take place earlier, meaning prior to 
conception or during routine prenatal doctor visits (Johnson et al., 2006).  
Research on earlier screening examined Misra’s (2003) Perinatal Health Lifespan Model, 
which seeks to understand approaches of mental health, detection, and treatment throughout the 
perinatal period (Leight, Fitelson, Weston, & Wisner, 2010). Misra’s model involves multiple 
phases over the span of a woman’s life, including preconception, prenatal, intrapartum, 
postpartum, and interconception (the time between the end of one pregnancy and the beginning 
of another), with the main focus of the model being “preconception and interconception” (Leight 
et al., 2010, p. 462; Misra, Guyer, & Allston, 2003). Misra’s research explains that severe 
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negative perinatal mental health outcomes can be avoided with an increased focus on screening 
and detecting conditions sooner and with more accuracy, and with quicker treatment for 
depression (Leight et al., 2010; Wisner, 2008).  
Another point of consideration is the act of pre-screening, or pre-identifying patients at 
risk for developing PMDs. Identification of PMD risk factors plays an integral role in the pre-
screening process. Healthcare providers should be aware of any previous family history of 
mental health disorders, as well as have an understanding of a patient’s socioeconomic position, 
and familial support situation (Rambelli et al., 2009). If healthcare providers are aware of these 
risk factors, they can administer screening tests sooner (Camp, 2013). Knowledge of these risk 
factors may also enable healthcare providers to engage in conversations about PMDs, or provide 
at-risk patients with literature on PMDs. It is important to note that while screening scales and 
tools are valuable in identifying mental health disorders, the act of screening on its own does not 
prevent PMDs, or show improvement in clinical outcomes (Gaynes et al., 2005; Gilbody, Trevor, 
& House, 2008; Leight et al., 2010). 
Despite the importance of screening, most participants in this study were not screened for 
PMDs. This may be partly due to the debate about which healthcare professionals are best suited 
for administering PMD screening. However, Tam et al. (2002, p. 81) emphasized that pediatric 
physicians offer an idyllic setting to screen for PMDs, due to the high frequency of well-baby 
appointments during an infant’s first year of life, as well as their ability to show concern for 
proper infant development. Tam et al. (2002) suggest that pediatricians should be instructed on 
PMD assessment methods and the referral process in order for them to allow time to address 
PMDs during well-baby visits. There are others who believe screening is the responsibility of the 
women’s obstetrician or gynecologist, or a nurse prior to the traditional postpartum appointment 
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(Kendig et al., 2017). Unfortunately, as Anderson (2011) explains, most women only see their 
physicians once for their postpartum appointment, and that appointment is often too early to 
recognize symptoms of PMDs as they differ from typical baby blues.  
Brown (2015) suggests that nonpsychiatric providers should exercise caution when it 
comes to screening patients for PMDs, as this may be a key to “Pandora’s Box.” However, 
awareness of PMDs can provide healthcare professionals with knowledge about a patient’s 
condition, and allow those healthcare professionals to refer patients if they are not comfortable 
with making a diagnosis or administering treatment (Brown, 2015). Camp (2013) explains that 
providers also need to be aware of various “nonverbal clues” displayed by patients that may 
warrant appropriate screening such as a disheveled appearance, a lack of interest in holding one’s 
baby, fatigue or tiredness, or crying.  
If women do not feel comfortable finding screening and referral help, they may remain 
untreated and subsequently, may encounter worsening of their conditions (Leight et al., 2010; 
Abrams, Dornig, & Curran, 2009; Dennis & Chung Lee, 2006). Unfortunately, as evidenced by 
the findings of this study, women are not being screened for PMDs. In the United States, only 13 
states have developed PMD policies and only four of those states possess screening mandates 
(Rowan, Duckett, & Wang, 2015). Mandates for screening exist in Illinois, Massachusetts, New 
Jersey, and West Virginia. Screening for PMDs is essential to understanding the number of PMD 
diagnoses and how those diagnoses are impacted by socioeconomic status, complications of 
pregnancy, prior health status, etc. This knowledge is important in developing mental health 
initiatives at the state level. 
 In addition to screening for PMDs, it is also important that healthcare professionals 
communicate with women about mental health. In this study, one participant indicated she had a 
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PMD discussion with a “pediatrician after my last birth…[because] I had an episode with the 
baby that concerned him.” This study found that many women did not receive communication, 
either written or oral, about PMDs before, during, or after pregnancy. Those who did mostly 
received information after pregnancy, via discussion with a physician. Only 27.7% of 
participants were offered literature during their pregnancies and only 1.9% were offered 
literature at their first prenatal visit. Also, less than half of participants (32.9%) reported having 
discussions about PMDs during the first prenatal visit or during their pregnancies. Of the 96 
participants who had discussions with healthcare providers about PMDs, 72.9% reported nurses 
and prescribers (physicians, nurse practitioners, and physician assistants) as the individuals who 
engaged in those discussions. These results showcase a need for more proactive literature 
offerings and increased discussion of PMDs. It is encouraging, however, that discussions are 
being held by nurses and prescribers. Unfortunately, daily demands placed on nurses and 
prescribers continue to be on the rise. Managed care challenges, increases in the numbers of 
patient visits, and recording patient data for quality measure reimbursement (i.e., blood pressure 
and cholesterol guidelines) are factors that influence the amount of time physicians and nurses 
can spend with patients. Therefore, it is necessary to explore ways in which other healthcare 
professionals, such as medical assistants, specialized office staff, or contracted social workers, 
can introduce the topic of PMDs to mothers. For instance, one participant noted that she obtained 
literature from a psychiatrist in a Women’s Mood Clinic and another reported having 
conversations with a nurse, doctor, and doula.  
Participants also reported other ways of receiving information, short of literature or 
personal discussion. One participant stated that she was given “an informational DVD that was 
to be watched before discharge.” Three other participants reported receiving videos after birth, as 
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well as standard hospital discharge paperwork and recalled possibly receiving an information 
packet. Another participant indicated receiving literature at a birth class.  
While it is important to applaud the efforts of healthcare providers who do screen for and 
communicate about PMDs, it is equally important to acknowledge that this is not a common 
practice. For many women, concerns about PMDs are dismissed. One participant reported 
being told by her doctor “to keep a strong mind.” While it is positive that this participant 
engaged in a discussion with her doctor, the comment is dismissive and provides no direction on 
how to address the patient’s situation. It is important for physicians to explain PMD materials to 
patients and also to listen to and acknowledge, and attempt to address patients’ concerns. Camp 
(2013) notes that healthcare providers should discuss the emotional components, as well as the 
physical components of pregnancy. If perinatal patients are aware of both the emotional and 
physical changes of pregnancy through proper communication that leads to increased knowledge 
and understanding, patients may feel more at ease when asking for help with PMD symptoms 
(Camp, 2013).  
Evidence that supports proactive PMD discussions with women during their pregnancies 
is outlined by Mao, Li, Chiu, Chan, & Chen (2012). Mao et al. (2012) examined discussion and 
distribution of PMD information during childbirth classes. They examined the efficacy of an 
“emotional self-management group training” program (ESMGT), which showed similar 
characteristics to that of cognitive behavioral therapy (CBT). Screening was performed prior to 
the start of the training/education programs and outcome measures were taken at pre and post 
intervention, as well as six weeks post-delivery, via the Patient Health Questionnaire-9 (PHQ-9) 
assessment, the EPDS, and the Structural Clinical Interview for DSM-IV (SCID). After 
completion of the ESMGT and standard education (36 weeks antenatal), the intervention group 
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showed a significantly lower (better) score than that of the control group. At the six-week 
postnatal mark, the intervention group’s EPDS score was significantly lower (better) than the 
control group’s score. In addition, the PHQ-9 and EPDS demonstrated that depressive symptoms 
improved significantly in the intervention group versus those symptoms in the control group. The 
intervention showed that improved communication decreased risk for PPD at the six-week 
postnatal mark (Mao et al., 2012).  
The Mao et al. (2012) study also underscores the importance of providing communication 
in alternative formats, outside the physician’s office, as their study focused on communication 
provided at childbirth classes. In this study, 112 of 155 participants attended childbirth classes. 
However, only 25.9% of those participants received PMD communication, either through 
discussions or literature disbursement. Early PMD awareness is vital in preparing women for all 
aspects of childbirth. Camp explains that, “patients need to know about the occurrence of PPD, 
what to look for, and what to do to get help should the warning signs be present” (2013, p. 49). If 
patients are better informed, they are also more prepared to act if they experience PMD 
symptoms. 
Discussion of Hypotheses  
 While no relationship was found to exist between participant age or education and 
knowledge of common PPD symptoms, it is important to note that this study’s participants were 
well-educated. As previously mentioned, most of the study participants received a Bachelor’s 
degree or higher, with 58 (37.4%) receiving a graduate or professional degree. This well-
educated sample makes it difficult to elucidate any real differences in age or education. Further, 
the Knowledge Gap Hypothesis indicates that higher socio-economic status leads to increased 
knowledge (Tichenor et al., 1970). Income information was not obtained in this study, so an 
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association between socioeconomic status and knowledge cannot be determined. Others, 
however, have studied patient demographics and associations with knowledge attainment in the 
context of PPD, finding demographic variables are related to a knowledge gap about PPD, with 
younger women with younger children, a higher education, and an urban location producing 
higher levels of knowledge about PPD (Anderson, 2011). Thus, it is important to continue 
exploring the impact of demographic characteristics and knowledge of PMDs.  
Study Limitations  
As with all research, there were limitations of this study. As mentioned, this was a well-
educated sample. Due to high levels of education, those participants might have been more aware 
of PMD conditions and symptomatology and they could have been more inclined to proactively 
initiate conversations about PMDs with their healthcare professionals. Additionally, as this study 
employed a convenient snowball sample that stemmed from the principal and student 
investigators’ social and professional networks, participant demographics were likely skewed 
towards the investigators. Also, the investigators’ contacts likely sent the survey to specific 
friends, family members, or colleagues who struggled with PMDs, thus creating a higher chance 
that the sample included women who experienced PMDs. 
Further, many participants indicated it had been more than 10 years since they had given 
birth. This may lead to participants experiencing difficulty recalling their perinatal experiences. 
As a result, these women might have selected answers that differed from their actual perinatal 
experiences. Additionally, PMD knowledge and awareness has changed drastically in the past 10 
years. Awareness has improved due in part to celebrity disclosures of PMDs and primetime 
television shows like Private Practice and Nashville dedicating storylines to characters with 
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PPD. This increased awareness may improve knowledge of PPD thereby causing participants to 
indicate higher knowledge of PPD than perhaps they had during their pregnancies.  
Lastly, this study lacks in both construct validity and high reliability. This could be 
improved through test-retest measures, and the inclusion of an expert panel to assess the 
questionnaire prior to being utilized again. However, the use of self-report questionnaires allows 
for measuring a construct that would be difficult to obtain otherwise. An increase in validity and 
reliability could be achieved by employing a stratified sampling process. The act of assigning 
“subgroups or subpopulations,” such as geographic location and income level, within the total 
population, would also increase generalizability in a larger sample size (Jones & Kottler, 2006, p. 
62).  
Recommendations for Future Research  
 There are many facets of PMDs that warrant additional research. One area of focus would 
be to examine the most effective methods of educating nurses, primary care physicians, 
specialists, pediatricians, and other related women’s health providers (i. e. medical assistants) 
about the necessity of screening and proper screening methods for PMDs. Another area ripe for 
research is the study of how women prefer to get information, and what ways are best for 
knowledge advancement and improved awareness. With healthcare professionals busier than 
ever before and pregnancy-specific mobile technology, it is worth exploring how effective it is 
for women to receive information via mobile apps or other technological tools. Additionally, it is 
important to study the development of, communication about, and screening behaviors in 
different populations. As this sample was well-educated, it is important to understand how 
lesser-education individuals receive and process information, in addition to individuals in other 
marginalized groups, such as rural patients, lower income patients, and young mothers. Lastly, it 
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is important to continue studying the ways in which stigma about PMDs affect disclosure of 
PMD symptoms and impact patient-provider relationships. 
Conclusion 
This study attempts to provide a better understanding of communication about PMDs and 
the screening behaviors of healthcare professionals. Findings of this study indicate a general lack 
of screening and communication about PMDs. It is important to continue research about these 
issues as increased screening and communication are related to decreased negative outcomes 
associated with PMDs. These findings have implications not only for the healthcare 
professionals who diagnose and treat PMDs, but the thousands of women who suffer with these 


















Email Recruitment Letter 
Hello, 
My name is Jodi Drake and I am a graduate student at Johns Hopkins University, 
conducting research for my Master’s thesis under the direction of Dr. LaKesha Anderson. I am 
collecting answers to a survey on postpartum depression and would be grateful for your 
participation. Your input is extremely important for increasing our understanding of perinatal 
mood disorders, as well as screening and communication about these conditions. You can be 
reassured that your answers will remain confidential and will not be linked to you as a 
participant.  
The survey should take no longer than 15 minutes to complete. The survey is available 
via: http://www.surveygizmo.com/s3/4033547/Perinatal-Mood-Disorder-Education-and-
Screening. 
I ask that you please forward this survey to any friends, colleagues, and family members 
who may be able to participate as well. I greatly appreciate your participation and thank you for 
your time.  
Kind Regards,  







Facebook/Twitter/LinkedIn Recruitment Post 
Calling All Mothers Ages 18+ 
I am conducting a research study on perinatal mood disorders for my thesis at Johns Hopkins 
University and would welcome your participation in an online survey. The survey should take no 
longer than 15 minutes to complete and can be found at 
http://www.surveygizmo.com/s3/4033547/Perinatal-Mood-Disorder-Education-and-Screening. 
Please forward this information anyone in your network who may be willing to participate as 




















Johns Hopkins University 
Homewood Institutional Review Board (HIRB) 
Informed Consent Form 
 
Title: Lifting the Fog: Provider Screening Behaviors and New Mothers' Knowledge of Perinatal 
Mood Disorders 
Principal Investigator:  LaKesha N. Anderson, Ph.D. 
Date: December 17, 2017 
 
PURPOSE OF RESEARCH STUDY:  
The objective of the current study is to uncover the amount and type of perinatal mood disorder 
information that women received throughout pregnancy and after delivery. This study also 
attempts to understand women's current knowledge of perinatal mood disorders. 
 
PROCEDURES: 
Participants are asked to complete a brief online survey. The time necessary to complete this 
survey is approximately 10 minutes.   
 
RISKS/DISCOMFORTS: 




There are no direct benefits to individuals from participating in this study. This study may 
benefit society if the results lead to a better understanding of perinatal mood disorder screening 
and communication. 
VOLUNTARY PARTICIPATION AND RIGHT TO WITHDRAW: 
Your participation in this study is entirely voluntary: You choose whether to participate. If you 
decide not to participate, there are no penalties, and you will not lose any benefits to which you 
would otherwise be entitled. 
If you choose to participate in the study, you can stop your participation at any time, without any 
penalty or loss of benefits. If you want to withdraw from the study, you can choose close the 
unfinished survey, or, if you have completed the survey but wish to have your survey destroyed, 
please contact the study’s student investigator, Jodi Drake, at jdrake11@jhu.edu.You will not be 





Any study records that identify you will be kept confidential to the extent possible by law. The 
records from your participation may be reviewed by people responsible for making sure that 
research is done properly, including members of the Johns Hopkins University Homewood 
Institutional Review Board and officials from government agencies such as the National 
Institutes of Health and the Office for Human Research Protections. (All of these people are 
required to keep your identity confidential.) Otherwise, records that identify you will 
be available only to people working on the study, unless you give permission for other people to 
see the records.  
All study records will be stored in a secure office desk accessible only to the researcher and 
student investigator. The online survey will remain confidential and access is permitted only by 
password, which is available only to the researcher and student investigator. 
 
COMPENSATION: 
You will not receive any payment or other compensation for participating in this study.  
 
IF YOU HAVE QUESTIONS OR CONCERNS: 
You can ask questions about this research study now or at any time during the study by emailing 
Dr. LaKesha Anderson at lander73@jhu.edu.  If you have questions about your rights as a 
research participant or feel that you have not been treated fairly, please call the Homewood 
Institutional Review Board at Johns Hopkins University at (410) 516-6580. 
 
SIGNATURE 
By entering the date below, you confirm that you are 18+ years of age and have given birth to an 
infant. You also confirm that you have read this informed consent form, and that you agree to 
participate in this study.  
 
Notes: The space for Question 1 was filled by the signature (date) line. Asterisks denote required 
questions.  
 
2. What is your highest level of education? * 
 
  Did not complete High School 
  High School Diploma 
  Some College 
  Associate's degree 
  Bachelor's degree 
  Master's degree 
  Doctoral degree 
  Professional degree (ex: MD, JD) 
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3. What is your age? * 
 
  18 to 24 
  25 to 34 
  35 to 44 
  45 to 54 
  55+ 
 
4. How long has it been since you last gave birth? * 
 
  Less than 1 year 
  1- 3 years 
  4-6 years 
  7-10 years 
  10 + years 
 
5. How familiar were you with symptoms of perinatal mood disorders including 
postpartum depression, postpartum anxiety, postpartum-induced OCD, or postpartum 
psychosis before pregnancy? * 
 
 Not at all familiar 
 Slightly familiar 
 Neutral 
 Very familiar 





        
6. Were you offered literature on perinatal mood disorders? (If you were offered literature 
multiple times, choose all answers that apply).  * 
 
  Yes, at my first prenatal visit 
  Yes, sometime during my pregnancy 
  Yes, after delivery 








7. If you answered yes to question #7, please specify from whom you were offered this 
literature.  
 
  Nurse 
  Physician/Nurse Practitioner/Physician Assistant 
  Doula/Midwife 
  Office staff 
  Other - Please Explain   
 
8. Did a healthcare team member discuss perinatal mood disorders with you? (If you had 
multiple discussions about perinatal mood disorders, choose all answers that apply).  * 
 
  Yes, during my first prenatal visit 
  Yes, sometime during my pregnancy 
  Yes, after delivery 
  No, perinatal mental health was not discussed with me at any time 
 
9. If you answered yes to question #9, please specify with whom you discussed perinatal 
mood disorders. 
 
  Nurse 
  Physician/Nurse Practitioner/Physician Assistant 
  Doula/Midwife 
  Office staff 
  Other - Please Explain   
 
10. Were you screened for perinatal mood disorders? (If you were screened multiple times, 
choose all answers that apply).  * 
 
  Yes, during my first prenatal visit 
  Yes, during my pregnancy 
  Yes, after delivery 






11. If you answered yes to question #11, who screened you for perinatal mood disorders? 
 
  Nurse 
  Physician/Nurse Practitioner/Physician Assistant 
  Doula/Midwife 
  Office or Hospital staff 
  Other - Please Explain   
 
12. Was perinatal mood disorder literature offered to you or discussed with you during 
childbirth classes? * 
 
  Yes 
  No 
  I did not attend childbirth classes 
 
13. Were you diagnosed with any mental health conditions or perinatal mood 
disorders prior to or during your pregnancy (i.e. depression, bipolar disorder)? * 
 
  Yes 
  No 
 
14. Were you diagnosed with any perinatal mood disorders after your pregnancy (i.e. 
postpartum depression, postpartum anxiety, postpartum OCD, or postpartum 
psychosis)? * 
 
  Yes 
  No 
 
15. Did you attend any support groups during or after your pregnancy? 
 
  Yes, I attended a general support group for new/expecting mothers. 
  Yes, I attended a support group specifically for women experiencing perinatal mood 
disorders (postpartum depression/anxiety/OCD/psychosis) 
  I attended another type of support group - Please Explain   
  I did not attend a support group of any kind 
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16. Which of the following are common symptoms of postpartum depression?  * 
 
  Feeling sad, hopeless, empty, or overwhelmed 
  Crying more often than usual or for no apparent reason 
  Feeling moody, irritable, or restless 
  Oversleeping, or being unable to sleep even when her baby is asleep 
  Having trouble concentrating, remembering details, and making decisions 
  Thinking about harming oneself or the baby 
  Persistently doubting own ability to care for the baby 
  Experiencing anger or rage 
  Having trouble bonding or forming an emotional attachment with the baby 
  Withdrawing from or avoiding friends and family 
  Suffering from physical aches and pains, including frequent headaches, stomach 
problems, and muscle pain 
  Eating too little or too much 
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